Q3'23 EBITDA Misses Expectations; 2023-26 Strategy Unveiled by CompanyFOREXGPW’s Analytical Coverage Support Programme 3.0
Navigating Mixed Signals: Update on Medicalgorithmics' ECG Business OutlookFOREXGPW’s Analytical Coverage Support Programme 3.0
Bioton's 3Q23 Financial Performance: Below Expectations with Production Downtime ImpactFOREXGPW’s Analytical Coverage Support Programme 3.0
Challenges and Opportunities: Bioton's 3Q23 Earnings Forecast Amidst Evolving Market DynamicsFOREXGPW’s Analytical Coverage Support Programme 3.0
Forecasts and Valuation Adjustments Following Fabrity Holding's Marketing Business SaleFOREXGPW’s Analytical Coverage Support Programme 3.0
Ailleron: Above-Average Margins, Double-Digit Earnings Growth, and Favorable ValuationFOREXGPW’s Analytical Coverage Support Programme 3.0
Initiating Coverage of Selena FM with a Buy Recommendation and PLN 40.4 Price TargetFOREXGPW’s Analytical Coverage Support Programme 3.0
ATM Grupa: Buy Rating Maintained with Caution Amidst Earnings Challenges and Growth ProspectsFOREXGPW’s Analytical Coverage Support Programme 3.0
Sensory Marketing Growth: IMS and the Closer Music ProjectFOREXGPW’s Analytical Coverage Support Programme 3.0
Unlocking Mabion's Potential: Transitioning from Biosimilars to Biologics CDMO ProviderFOREXGPW’s Analytical Coverage Support Programme 3.0